Skip to main content
Erschienen in: Clinical & Experimental Metastasis 2/2008

01.04.2008 | Review

The tumor cell–host organ interface in the early onset of metastatic organ colonisation

verfasst von: Peter Gassmann, Joerg Haier

Erschienen in: Clinical & Experimental Metastasis | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

Metastatic lesions are the leading cause of death among cancer patients. These lesions usually originate from clonal proliferation of single tumor cells dispersed from the primary tumor into the circulation which finally arrest in the capillary bed of distant organs. The microenvironment within the circulation of potential metastatic target organs provides a variety of pro- and anti- metastatic stimuli regulating the onset of organ colonisation by metastatic tumor cells. Mechanical shear stress, anoikis and cell mediated cytotoxicity within the microcirculation probably clear most circulating tumor cells. Adhesion, and eventually extravasation, are essential initial interactions of circulating tumor cells with distant organs and can provide escape from the cytotoxic environment within the circulation. Adhesion to the capillary wall is mostly controlled by the organ-specific availability of adhesion molecules on tumor cells, the endothelium, and the composition of the underlying extracellular matrix. The availability of pro-adhesive and pro-migratory paracrine signals provided by the organ specific microenvironment can further initiate the onset of metastatic organ colonisation. Tumor cell and microenvironment factors regulating survival within the microcirculation, adhesion and extravasation of tumor cells are highlighted in the review.
Literatur
1.
Zurück zum Zitat Morris M, Iacopetta B, Platell C (2007) Comparing survival outcomes for patients with colorectal cancer treated in public and private hospitals. Med J Aust 186:296–300PubMed Morris M, Iacopetta B, Platell C (2007) Comparing survival outcomes for patients with colorectal cancer treated in public and private hospitals. Med J Aust 186:296–300PubMed
2.
Zurück zum Zitat Garcia-Closas M, Brinton LA, Lissowska J et al (2006) Established breast cancer risk factors by clinically important tumour characteristics. Br J Cancer 95:123–129PubMed Garcia-Closas M, Brinton LA, Lissowska J et al (2006) Established breast cancer risk factors by clinically important tumour characteristics. Br J Cancer 95:123–129PubMed
3.
Zurück zum Zitat Wolfle U, Muller V, Pantel K (2006) Disseminated tumor cells in breast cancer: detection, characterization and clinical relevance. Future Oncol 2:553–561PubMed Wolfle U, Muller V, Pantel K (2006) Disseminated tumor cells in breast cancer: detection, characterization and clinical relevance. Future Oncol 2:553–561PubMed
4.
Zurück zum Zitat Nicolson GL (1988) Cancer metastasis: TC and host organ properties important in metastasis to specific secondary sites. Biochem Biophys Acta 948:175–224PubMed Nicolson GL (1988) Cancer metastasis: TC and host organ properties important in metastasis to specific secondary sites. Biochem Biophys Acta 948:175–224PubMed
5.
Zurück zum Zitat Weiss L (1992) Comments on hematogenous metastatic patterns in humans as revealed by autopsy. Clin Exp Metastasis 10:191–199PubMed Weiss L (1992) Comments on hematogenous metastatic patterns in humans as revealed by autopsy. Clin Exp Metastasis 10:191–199PubMed
6.
Zurück zum Zitat Fidler IJ (2003) The pathogenesis of cancer metastasis: the seed and soil hypothesis revisited. Nat Rev Cancer 3:1–6 Fidler IJ (2003) The pathogenesis of cancer metastasis: the seed and soil hypothesis revisited. Nat Rev Cancer 3:1–6
7.
Zurück zum Zitat Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70PubMed Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70PubMed
8.
Zurück zum Zitat Thompson EW, Newgreen DF (2005) Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res 65:5991–5995PubMed Thompson EW, Newgreen DF (2005) Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res 65:5991–5995PubMed
9.
Zurück zum Zitat Guarino M, Rubino B, Ballabio G (2007) The role of epithelial-mesenchymal transition in cancer pathology. Pathology 39:305–318PubMed Guarino M, Rubino B, Ballabio G (2007) The role of epithelial-mesenchymal transition in cancer pathology. Pathology 39:305–318PubMed
10.
Zurück zum Zitat Tse JC, Kalluri R (2007) Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem. 101:816–829PubMed Tse JC, Kalluri R (2007) Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem. 101:816–829PubMed
11.
Zurück zum Zitat Grünert S, Jechlinger M, Beug H (2003) Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nature Rev/Mol Cell Biol 4:657–665 Grünert S, Jechlinger M, Beug H (2003) Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nature Rev/Mol Cell Biol 4:657–665
12.
Zurück zum Zitat Timmers M, Vekemans K, Vermijlen D et al (2004) Interactions between rat colon carcinoma cells and Kupffer cells during the onset of hepatic metastasis. Int J Cancer 112:793–802PubMed Timmers M, Vekemans K, Vermijlen D et al (2004) Interactions between rat colon carcinoma cells and Kupffer cells during the onset of hepatic metastasis. Int J Cancer 112:793–802PubMed
13.
Zurück zum Zitat Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563–572PubMed Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563–572PubMed
14.
Zurück zum Zitat Ewing J (1928) Neoplastic diseases, 6th edn. W. B. Sanders, Philadelphia Ewing J (1928) Neoplastic diseases, 6th edn. W. B. Sanders, Philadelphia
15.
Zurück zum Zitat Paget S (1889) The distribution of secondary growth in cancer of the breast. Lancet 1:571–573 Paget S (1889) The distribution of secondary growth in cancer of the breast. Lancet 1:571–573
16.
Zurück zum Zitat Weiss L, Voit A, Lane WW (1984) Metastatic patterns in patients with carcinoma of the lower esophagus and upper rectum. Invasion Metastasis 4:47–60PubMed Weiss L, Voit A, Lane WW (1984) Metastatic patterns in patients with carcinoma of the lower esophagus and upper rectum. Invasion Metastasis 4:47–60PubMed
17.
Zurück zum Zitat Tarin D, Price JE, Kettlewell MG et al (1984) Clinicopathological observations on metastasis in man studied in patients treated with peritoneovenous shunts. Br Med J (Clin Res Ed) 288:749–751CrossRef Tarin D, Price JE, Kettlewell MG et al (1984) Clinicopathological observations on metastasis in man studied in patients treated with peritoneovenous shunts. Br Med J (Clin Res Ed) 288:749–751CrossRef
18.
Zurück zum Zitat Tarin D, Price JE, Kettlewell MG et al (1984) Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. Cancer Res 44:3584–3592PubMed Tarin D, Price JE, Kettlewell MG et al (1984) Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. Cancer Res 44:3584–3592PubMed
19.
Zurück zum Zitat Muller A, Homey B, Soto H et al (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50–56PubMed Muller A, Homey B, Soto H et al (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50–56PubMed
20.
Zurück zum Zitat Glaves D, Huben RP, Weiss L (1988) Haematogeneous dissemination of cells from human renal adenocarcinomas. Br J Cancer 57:32–35PubMed Glaves D, Huben RP, Weiss L (1988) Haematogeneous dissemination of cells from human renal adenocarcinomas. Br J Cancer 57:32–35PubMed
21.
Zurück zum Zitat Glaves D, Ketch DA, Asch BB (1993) Conservation of epithelial cell phenotypes during hematogeneous metastasis from mammary carcinomas. J Natl Cancer Inst 76:933–938 Glaves D, Ketch DA, Asch BB (1993) Conservation of epithelial cell phenotypes during hematogeneous metastasis from mammary carcinomas. J Natl Cancer Inst 76:933–938
22.
Zurück zum Zitat Barbera-Guillem E, Weiss L (1993) Cancer-cell traffic in the liver. III Lethal deformation of B16 melanoma cells in liver sinusoids. Int J Cancer 54:880–884PubMed Barbera-Guillem E, Weiss L (1993) Cancer-cell traffic in the liver. III Lethal deformation of B16 melanoma cells in liver sinusoids. Int J Cancer 54:880–884PubMed
23.
Zurück zum Zitat Weiss L, Nannmark U, Johansson BR et al (1992) Lethal deformation of cancer cells in the microcirculation: a potential rate regulator of hematogenous metastasis. Int J Cancer 50:103–107PubMed Weiss L, Nannmark U, Johansson BR et al (1992) Lethal deformation of cancer cells in the microcirculation: a potential rate regulator of hematogenous metastasis. Int J Cancer 50:103–107PubMed
24.
Zurück zum Zitat Weiss L (1991) Deformation-driven, lethal damage to cancer cells. Its contribution to metastatic inefficiency. Cell Biophys 18:73–79PubMed Weiss L (1991) Deformation-driven, lethal damage to cancer cells. Its contribution to metastatic inefficiency. Cell Biophys 18:73–79PubMed
25.
Zurück zum Zitat Weiss L, Harlos JP, Elkin G (1990) Mechanisms for the biomechanical destruction of L1210 leukemia cells: a rate regulator for metastasis. Cell Biophys 16:149–159PubMed Weiss L, Harlos JP, Elkin G (1990) Mechanisms for the biomechanical destruction of L1210 leukemia cells: a rate regulator for metastasis. Cell Biophys 16:149–159PubMed
26.
Zurück zum Zitat Weiss L (1988) Biomechanical destruction of cancer cells in the heart: a rate regulator for hematogenous metastasis. Invasion Metastasis 8:228–237PubMed Weiss L (1988) Biomechanical destruction of cancer cells in the heart: a rate regulator for hematogenous metastasis. Invasion Metastasis 8:228–237PubMed
27.
Zurück zum Zitat Weiss L (1989) Biomechanical destruction of cancer cells in skeletal muscle: a rate-regulator for hematogenous metastasis. Clin Exp Metastasis 7:483–491PubMed Weiss L (1989) Biomechanical destruction of cancer cells in skeletal muscle: a rate-regulator for hematogenous metastasis. Clin Exp Metastasis 7:483–491PubMed
28.
Zurück zum Zitat Haier J, Nicolson GL (2001) Tumor cell adhesion under hydrodynamic conditions of fluid flow. APMIS 109:241–262PubMed Haier J, Nicolson GL (2001) Tumor cell adhesion under hydrodynamic conditions of fluid flow. APMIS 109:241–262PubMed
29.
Zurück zum Zitat Kucik DF, Dustin ML, Miller JM (1996) Adhesion-activating phorbol ester increases the mobility of leukocyte integrin LFA-1 in cultured lymphocytes. J Clin Invest 97:2139–2144PubMed Kucik DF, Dustin ML, Miller JM (1996) Adhesion-activating phorbol ester increases the mobility of leukocyte integrin LFA-1 in cultured lymphocytes. J Clin Invest 97:2139–2144PubMed
30.
Zurück zum Zitat Ni N, Kevil CG, Bullard DC et al (2003) Avidity modulation activates adhesion under flow and requires cooperativity among adhesion receptors. Biophys J 85:4122–4133 Ni N, Kevil CG, Bullard DC et al (2003) Avidity modulation activates adhesion under flow and requires cooperativity among adhesion receptors. Biophys J 85:4122–4133
31.
Zurück zum Zitat Korb T, Schlüter K, Enns A et al (2004) Integrity of actin fibres and microtubules influences metastatic tumor cell adhesion. Exp Cell Res 299:236–247PubMed Korb T, Schlüter K, Enns A et al (2004) Integrity of actin fibres and microtubules influences metastatic tumor cell adhesion. Exp Cell Res 299:236–247PubMed
32.
Zurück zum Zitat McIntire LV (1994) 1992 ALZA distinguished lecture: bioengineering and vascular biology. Ann Biomed Eng 22:2–13PubMed McIntire LV (1994) 1992 ALZA distinguished lecture: bioengineering and vascular biology. Ann Biomed Eng 22:2–13PubMed
33.
Zurück zum Zitat Galbraith CG, Sheetz MP (1998) Forces on adhesive contacts affect cell function. Curr Opin Cell Biol 10:566–571PubMed Galbraith CG, Sheetz MP (1998) Forces on adhesive contacts affect cell function. Curr Opin Cell Biol 10:566–571PubMed
34.
Zurück zum Zitat von Sengbusch A, Gassmann P, Fisch K et al (2005) Focal Adhesion Kinase regulates dynamic adhesion of carcinoma cells to collagens. Am J Pathol 166:585–593 von Sengbusch A, Gassmann P, Fisch K et al (2005) Focal Adhesion Kinase regulates dynamic adhesion of carcinoma cells to collagens. Am J Pathol 166:585–593
35.
Zurück zum Zitat Okuyama M, Ohta Y, Kambayashi J et al (1996) Fluid shear stress induces actin polymerization in human neutrophils. J Cell Biochem 63:432–441PubMed Okuyama M, Ohta Y, Kambayashi J et al (1996) Fluid shear stress induces actin polymerization in human neutrophils. J Cell Biochem 63:432–441PubMed
36.
Zurück zum Zitat Haier J, Nicolson GL (2000) Tumor cell adhesion of human colon carcinoma cells with different metastatic properties to extracellular matrix under dynamic conditions of laminar flow. J Cancer Res Clin Oncol 126:699–706PubMed Haier J, Nicolson GL (2000) Tumor cell adhesion of human colon carcinoma cells with different metastatic properties to extracellular matrix under dynamic conditions of laminar flow. J Cancer Res Clin Oncol 126:699–706PubMed
37.
Zurück zum Zitat Glinskii OV, Huxley VH, Glinsky GV et al (2005) Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs. Neoplasia 7:522–527PubMed Glinskii OV, Huxley VH, Glinsky GV et al (2005) Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs. Neoplasia 7:522–527PubMed
38.
Zurück zum Zitat Mook OR, Van Marle J, Vreeling-Sindelarova H et al (2003) Visualization of early events in tumor formation of eGFP-transfected rat colon cancer cells in liver. Hepatology 38:295–304PubMed Mook OR, Van Marle J, Vreeling-Sindelarova H et al (2003) Visualization of early events in tumor formation of eGFP-transfected rat colon cancer cells in liver. Hepatology 38:295–304PubMed
39.
Zurück zum Zitat Steinbauer M, Guba M, Cernaianu G et al (2003) GFP-transfected tumor cells are useful in examining early metastasis in vivo, but immune reaction precludes long-term tumor development studies in immunocompetent mice. Clin Exp Metastasis 20:135–141PubMed Steinbauer M, Guba M, Cernaianu G et al (2003) GFP-transfected tumor cells are useful in examining early metastasis in vivo, but immune reaction precludes long-term tumor development studies in immunocompetent mice. Clin Exp Metastasis 20:135–141PubMed
40.
Zurück zum Zitat Ding L, Sunamura M, Kodama T et al (2001) In vivo evaluation of the early events associated with liver metastasis of circulating cancer cells. Br J Cancer 85:431–438PubMed Ding L, Sunamura M, Kodama T et al (2001) In vivo evaluation of the early events associated with liver metastasis of circulating cancer cells. Br J Cancer 85:431–438PubMed
41.
Zurück zum Zitat Enns A, Gassmann P, Schluter K et al (2004) Integrins can directly mediate metastatic tumor cell adhesion within the liver sinusoids. J Gastrointest Surg 8:1049–1059PubMed Enns A, Gassmann P, Schluter K et al (2004) Integrins can directly mediate metastatic tumor cell adhesion within the liver sinusoids. J Gastrointest Surg 8:1049–1059PubMed
42.
Zurück zum Zitat Enns A, Korb T, Schluter K et al (2005) Alphavbeta5-integrins mediate early steps of metastasis formation. Eur J Cancer 41:1065–1072PubMed Enns A, Korb T, Schluter K et al (2005) Alphavbeta5-integrins mediate early steps of metastasis formation. Eur J Cancer 41:1065–1072PubMed
43.
Zurück zum Zitat Haier J, Korb T, Hotz B et al (2003) An intravital model to monitor steps of metastatic tumor cell adhesion within the hepatic microcirculation. J Gastrointest Surg 7:507–514PubMed Haier J, Korb T, Hotz B et al (2003) An intravital model to monitor steps of metastatic tumor cell adhesion within the hepatic microcirculation. J Gastrointest Surg 7:507–514PubMed
44.
Zurück zum Zitat Wang H, Fu W, Im JH et al (2004) Tumor cell alpha3beta1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis. J Cell Biol 164:935–941PubMed Wang H, Fu W, Im JH et al (2004) Tumor cell alpha3beta1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis. J Cell Biol 164:935–941PubMed
45.
Zurück zum Zitat Al-Mehdi AB, Tozawa K, Fisher AB et al (2000) Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med 6:100–102PubMed Al-Mehdi AB, Tozawa K, Fisher AB et al (2000) Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med 6:100–102PubMed
46.
Zurück zum Zitat MacDonald IC, Schmidt EE, Morris VL et al (1992) Intravital videomicroscopy of the chorioallantoic microcirculation: a model system for studying metastasis. Microvasc Res 44:185–199PubMed MacDonald IC, Schmidt EE, Morris VL et al (1992) Intravital videomicroscopy of the chorioallantoic microcirculation: a model system for studying metastasis. Microvasc Res 44:185–199PubMed
47.
Zurück zum Zitat Naumov GN, Wilson SM, MacDonald IC et al (1992) Cellular expression of green fluorescent protein, coupled with high-resolution in vivo videomicroscopy, to monitor steps in tumor metastasis. J Cell Sci 112:1835–1842 Naumov GN, Wilson SM, MacDonald IC et al (1992) Cellular expression of green fluorescent protein, coupled with high-resolution in vivo videomicroscopy, to monitor steps in tumor metastasis. J Cell Sci 112:1835–1842
48.
Zurück zum Zitat Karpatkin S, Pearlstein E (1981) Role of platelets in tumor cell metastases. Ann Intern Med 95:636–641PubMed Karpatkin S, Pearlstein E (1981) Role of platelets in tumor cell metastases. Ann Intern Med 95:636–641PubMed
49.
Zurück zum Zitat Palumbo JS, Talmage KE, Massari JV et al (2005) Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 105:178–185PubMed Palumbo JS, Talmage KE, Massari JV et al (2005) Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 105:178–185PubMed
50.
Zurück zum Zitat Nakamori S, Kameyama M, Imaoka S et al (1993) Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res 53:3632–3637PubMed Nakamori S, Kameyama M, Imaoka S et al (1993) Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res 53:3632–3637PubMed
51.
Zurück zum Zitat Amado M, Carneiro F, Seixas M et al (1998) Dimeric sialyl-Le(x) expression in gastric carcinoma correlates with venous invasion and poor outcome. Gastroenterology 114:462–470PubMed Amado M, Carneiro F, Seixas M et al (1998) Dimeric sialyl-Le(x) expression in gastric carcinoma correlates with venous invasion and poor outcome. Gastroenterology 114:462–470PubMed
52.
Zurück zum Zitat Steinert BW, Tang DG, Grossi IM et al (1993) Studies on the role of platelet eicosanoid metabolism and integrin alpha IIb beta 3 in tumor-cell-induced platelet aggregation. Int J Cancer 54:92–101PubMed Steinert BW, Tang DG, Grossi IM et al (1993) Studies on the role of platelet eicosanoid metabolism and integrin alpha IIb beta 3 in tumor-cell-induced platelet aggregation. Int J Cancer 54:92–101PubMed
53.
Zurück zum Zitat Borsig L, Wong R, Hynes RO et al (2002) Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc Natl Acad Sci USA 99:2193–2198PubMed Borsig L, Wong R, Hynes RO et al (2002) Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc Natl Acad Sci USA 99:2193–2198PubMed
54.
Zurück zum Zitat Camerer E, Qazi AA, Duong DN et al (2004) Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood 104:397–401PubMed Camerer E, Qazi AA, Duong DN et al (2004) Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood 104:397–401PubMed
55.
Zurück zum Zitat Amirkhosravi A, Mousa SA, Amaya M et al (2003) Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454. Thromb Haemost 90:549–554PubMed Amirkhosravi A, Mousa SA, Amaya M et al (2003) Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454. Thromb Haemost 90:549–554PubMed
56.
Zurück zum Zitat Klepfish A, Greco MA, Karpatkin S (1993) Thrombin stimulates melanoma tumor-cell binding to endothelial cells and subendothelial matrix. Int J Cancer 53:978–982PubMed Klepfish A, Greco MA, Karpatkin S (1993) Thrombin stimulates melanoma tumor-cell binding to endothelial cells and subendothelial matrix. Int J Cancer 53:978–982PubMed
57.
Zurück zum Zitat Dardik R, Savion N, Kaufmann Y et al (1998) Thrombin promotes platelet-mediated melanoma cell adhesion to endothelial cells under flow conditions: role of platelet glycoproteins P-selectin and GPIIb-IIIA. Br J Cancer 77:2069–2075PubMed Dardik R, Savion N, Kaufmann Y et al (1998) Thrombin promotes platelet-mediated melanoma cell adhesion to endothelial cells under flow conditions: role of platelet glycoproteins P-selectin and GPIIb-IIIA. Br J Cancer 77:2069–2075PubMed
58.
Zurück zum Zitat Honn KV, Tang DG, Grossi IM et al (1994) Enhanced endothelial cell retraction mediated by 12(S)-HETE: a proposed mechanism for the role of platelets in tumor cell metastasis. Exp Cell Res 210:1–9PubMed Honn KV, Tang DG, Grossi IM et al (1994) Enhanced endothelial cell retraction mediated by 12(S)-HETE: a proposed mechanism for the role of platelets in tumor cell metastasis. Exp Cell Res 210:1–9PubMed
59.
Zurück zum Zitat Liotta LA (1992) Cancer cell invasion and metastasis. Sci Am 266:54–59, 62–63 Liotta LA (1992) Cancer cell invasion and metastasis. Sci Am 266:54–59, 62–63
60.
Zurück zum Zitat Dong C, Slattery MJ, Rank BM (2002) In vitro characterization and micromechanics of tumor cell chemotactic protrusion, locomotion, and extravasation. Ann Biomed Eng 30:344–355PubMed Dong C, Slattery MJ, Rank BM (2002) In vitro characterization and micromechanics of tumor cell chemotactic protrusion, locomotion, and extravasation. Ann Biomed Eng 30:344–355PubMed
61.
Zurück zum Zitat Slattery MJ, Dong C (2003) Neutrophils influence melanoma adhesion and migration under flow conditions. Int J Cancer 106:713–722PubMed Slattery MJ, Dong C (2003) Neutrophils influence melanoma adhesion and migration under flow conditions. Int J Cancer 106:713–722PubMed
62.
Zurück zum Zitat Slattery MJ, Liang S, Dong C (2005) Distinct role of hydrodynamic shear in leukocyte-facilitated tumor cell extravasation. Am J Physiol Cell Physiol 288:C831–C839PubMed Slattery MJ, Liang S, Dong C (2005) Distinct role of hydrodynamic shear in leukocyte-facilitated tumor cell extravasation. Am J Physiol Cell Physiol 288:C831–C839PubMed
63.
Zurück zum Zitat Wu QD, Wang JH, Condron C et al (2001) Human neutrophils facilitate tumor cell transendothelial migration. Am J Physiol Cell Physiol 280:C814–C822PubMed Wu QD, Wang JH, Condron C et al (2001) Human neutrophils facilitate tumor cell transendothelial migration. Am J Physiol Cell Physiol 280:C814–C822PubMed
64.
Zurück zum Zitat Khatib AM, Fallavollita L, Wancewicz EV et al (2002) Inhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasis. Cancer Res 62:5393–5398PubMed Khatib AM, Fallavollita L, Wancewicz EV et al (2002) Inhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasis. Cancer Res 62:5393–5398PubMed
65.
Zurück zum Zitat Kim YJ, Borsig L, Han HL et al (1999) Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium. Am J Pathol 155:461–472PubMed Kim YJ, Borsig L, Han HL et al (1999) Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium. Am J Pathol 155:461–472PubMed
66.
Zurück zum Zitat Wisse E, van’t Noordende JM, van der Meulen J et al (1976) The pit cell: description of a new type of cell occurring in rat liver sinusoids and peripheral blood. Cell Tissue Res 173:423–435PubMed Wisse E, van’t Noordende JM, van der Meulen J et al (1976) The pit cell: description of a new type of cell occurring in rat liver sinusoids and peripheral blood. Cell Tissue Res 173:423–435PubMed
67.
Zurück zum Zitat Grundy MA, Zhang T, Sentmann CL (2007) NK cells remove B16F10 tumor cells in a perforin and interferon-gamma independent manner in vivo. Cancer Immunol Immunother 56:1153–1161PubMed Grundy MA, Zhang T, Sentmann CL (2007) NK cells remove B16F10 tumor cells in a perforin and interferon-gamma independent manner in vivo. Cancer Immunol Immunother 56:1153–1161PubMed
68.
Zurück zum Zitat Wiltrout RH (2000) Regulation and antimetastatic functions of liver-associated natural killer cells. Immunol Rev 174:63–76PubMed Wiltrout RH (2000) Regulation and antimetastatic functions of liver-associated natural killer cells. Immunol Rev 174:63–76PubMed
69.
Zurück zum Zitat Vermijlen D, Luo D, Robaye B et al (1999) Pit cells (Hepatic natural killer cells) of the rat induce apoptosis in colon carcinoma cells by the perforin/granzyme pathway. Hepatology 29:51–56PubMed Vermijlen D, Luo D, Robaye B et al (1999) Pit cells (Hepatic natural killer cells) of the rat induce apoptosis in colon carcinoma cells by the perforin/granzyme pathway. Hepatology 29:51–56PubMed
70.
Zurück zum Zitat Shresta S, MacIvor DM, Heusel JW et al (1995) Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells. Proc Natl Acad Sci USA 92:5679–5683PubMed Shresta S, MacIvor DM, Heusel JW et al (1995) Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells. Proc Natl Acad Sci USA 92:5679–5683PubMed
71.
Zurück zum Zitat Oshimi Y, Oda S, Honda Y et al (1996) Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J Immunol 157:2909–2915PubMed Oshimi Y, Oda S, Honda Y et al (1996) Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J Immunol 157:2909–2915PubMed
72.
Zurück zum Zitat Wiltrout RH, Herberman RB, Zhang SR et al (1985) Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J Immunol 134:4267–4275PubMed Wiltrout RH, Herberman RB, Zhang SR et al (1985) Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J Immunol 134:4267–4275PubMed
73.
Zurück zum Zitat Smyth MJ, Thia KY, Street SE et al (2000) Differential tumor surveillance by natural killer (NK) and NKT cells. J Exp Med 191:661–668PubMed Smyth MJ, Thia KY, Street SE et al (2000) Differential tumor surveillance by natural killer (NK) and NKT cells. J Exp Med 191:661–668PubMed
74.
Zurück zum Zitat Smyth MJ, Taniguchi M, Street SE (2000) The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent. J Immunol 165:2665–2670PubMed Smyth MJ, Taniguchi M, Street SE (2000) The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent. J Immunol 165:2665–2670PubMed
75.
Zurück zum Zitat Gardner CR, Wasserman AJ, Laskin DL (1987) Differential sensitivity of tumor targets to liver macrophage-mediated cytotoxicity. Cancer Res 47:6686–6691PubMed Gardner CR, Wasserman AJ, Laskin DL (1987) Differential sensitivity of tumor targets to liver macrophage-mediated cytotoxicity. Cancer Res 47:6686–6691PubMed
76.
Zurück zum Zitat Decker T, Kiderlen AF, Lohmann-Matthes ML (1985) Liver macrophages (Kupffer cells) as cytotoxic effector cells in extracellular and intracellular cytotoxicity. Infect Immun 50:358–364PubMed Decker T, Kiderlen AF, Lohmann-Matthes ML (1985) Liver macrophages (Kupffer cells) as cytotoxic effector cells in extracellular and intracellular cytotoxicity. Infect Immun 50:358–364PubMed
77.
Zurück zum Zitat Sturm JW, Magdeburg R, Berger K (2003) Influence of TNFA on the formation of liver metastases in a syngenic mouse model. Int J Cancer 107:11–21PubMed Sturm JW, Magdeburg R, Berger K (2003) Influence of TNFA on the formation of liver metastases in a syngenic mouse model. Int J Cancer 107:11–21PubMed
78.
Zurück zum Zitat Fingar VH, Taber SW, Buschemeyer WC (1997) Constitutive and stimulated expression of ICAM-1 protein on pulmonary endothelial cells in vivo. Microvasc Res 54:135–144PubMed Fingar VH, Taber SW, Buschemeyer WC (1997) Constitutive and stimulated expression of ICAM-1 protein on pulmonary endothelial cells in vivo. Microvasc Res 54:135–144PubMed
79.
Zurück zum Zitat Heimburg J, Yan J, Morey S et al (2006) Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11. Neoplasia 8:939–948PubMed Heimburg J, Yan J, Morey S et al (2006) Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11. Neoplasia 8:939–948PubMed
80.
Zurück zum Zitat Ito S, Nakanishi H, Ikehara Y (2001) Real-time observation of micrometastasis formation in the living mouse liver using a green fluorescent protein gene-tagged rat tongue carcinoma cell line. Int J Cancer 93:212–217PubMed Ito S, Nakanishi H, Ikehara Y (2001) Real-time observation of micrometastasis formation in the living mouse liver using a green fluorescent protein gene-tagged rat tongue carcinoma cell line. Int J Cancer 93:212–217PubMed
81.
Zurück zum Zitat Shimizu S, Yamada N, Sawada T et al (2001) Ultrastructure of early phase hepatic metastasis of human colon carcinoma cells with special reference to desmosomal junctions with hepatocytes. Pathol Int 50:953–959 Shimizu S, Yamada N, Sawada T et al (2001) Ultrastructure of early phase hepatic metastasis of human colon carcinoma cells with special reference to desmosomal junctions with hepatocytes. Pathol Int 50:953–959
82.
Zurück zum Zitat Khatib AM, Kontogiannea M, Fallavollita L et al. (1999). Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells. Cancer Res 59:1356–1361PubMed Khatib AM, Kontogiannea M, Fallavollita L et al. (1999). Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells. Cancer Res 59:1356–1361PubMed
83.
Zurück zum Zitat Wang HH, McIntosh AR, Hasinoff BB et al (2002) Regulation of B16F1 melanoma cell metastasis by inducible functions of the hepatic microvasculature. Eur J Cancer 38:1261–1270PubMed Wang HH, McIntosh AR, Hasinoff BB et al (2002) Regulation of B16F1 melanoma cell metastasis by inducible functions of the hepatic microvasculature. Eur J Cancer 38:1261–1270PubMed
84.
Zurück zum Zitat Orr FW, Wang HH, Lafrenie RM et al (2000) Interactions between cancer cells and the endothelium in metastasis. J Pathol 190:310–329PubMed Orr FW, Wang HH, Lafrenie RM et al (2000) Interactions between cancer cells and the endothelium in metastasis. J Pathol 190:310–329PubMed
85.
Zurück zum Zitat Eble JA, Haier J (2006) Integrins in cancer treatment. Curr Cancer Drug Targets 6:89–105PubMed Eble JA, Haier J (2006) Integrins in cancer treatment. Curr Cancer Drug Targets 6:89–105PubMed
86.
Zurück zum Zitat Meyer T, Hart IR (1998) Mechanisms of tumour metastasis. Eur J Cancer 34:214–221PubMed Meyer T, Hart IR (1998) Mechanisms of tumour metastasis. Eur J Cancer 34:214–221PubMed
87.
Zurück zum Zitat Gooding JM, Yap KL, Ikura M (2004) The cadherin–catenin complex as a focal point of cell adhesion and signalling: new insights from three-dimensional structures. Bioessays 26:497–511PubMed Gooding JM, Yap KL, Ikura M (2004) The cadherin–catenin complex as a focal point of cell adhesion and signalling: new insights from three-dimensional structures. Bioessays 26:497–511PubMed
88.
Zurück zum Zitat Silbert JE, Sugumaran G (2003) A starting place for the road to function. Glycoconj 19:227–237 Silbert JE, Sugumaran G (2003) A starting place for the road to function. Glycoconj 19:227–237
89.
Zurück zum Zitat Haier J, Nasralla M, Nicolson GL (2000) Cell surface molecules and their prognostic values in assessing colorectal carcinomas. Ann Surg 231:11–24PubMed Haier J, Nasralla M, Nicolson GL (2000) Cell surface molecules and their prognostic values in assessing colorectal carcinomas. Ann Surg 231:11–24PubMed
90.
Zurück zum Zitat Juliano RL, Varner JA (1993) Adhesion molecules in cancer: the role of integrins. Curr Opin Cell Biol 5:812–818PubMed Juliano RL, Varner JA (1993) Adhesion molecules in cancer: the role of integrins. Curr Opin Cell Biol 5:812–818PubMed
91.
Zurück zum Zitat Hulleman E, Boonstra J (2001) Regulation of G1 phase progression by growth factors and the extracellular matrix. Cell Mol Life Sci 58:80–93PubMed Hulleman E, Boonstra J (2001) Regulation of G1 phase progression by growth factors and the extracellular matrix. Cell Mol Life Sci 58:80–93PubMed
92.
Zurück zum Zitat Juliano RL, Varner JA (1993) Adhesion molecules in cancer: the role of integrins. Curr Opin Cell Biol 5:812–818PubMed Juliano RL, Varner JA (1993) Adhesion molecules in cancer: the role of integrins. Curr Opin Cell Biol 5:812–818PubMed
93.
Zurück zum Zitat Varner JA, Emerson DA, Juliano RL (1995) Integrin alpha5beta1 expression negatively regulate cell growth: reversal by attachment to fibronectin. Mol Biol Cell 6:725–740PubMed Varner JA, Emerson DA, Juliano RL (1995) Integrin alpha5beta1 expression negatively regulate cell growth: reversal by attachment to fibronectin. Mol Biol Cell 6:725–740PubMed
94.
Zurück zum Zitat Derksen PW, Liu X, Saridin F et al (2006) Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 10:437–449PubMed Derksen PW, Liu X, Saridin F et al (2006) Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 10:437–449PubMed
95.
Zurück zum Zitat Owens DM, Watt FM (2001) Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion. Cancer Res 61:5248–5254PubMed Owens DM, Watt FM (2001) Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion. Cancer Res 61:5248–5254PubMed
96.
Zurück zum Zitat Zutter MM, Santoro SA, Staatz WD (1995) Re-expression of the alpha2beta1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc Natl Acad Sci USA 92:7411–7415PubMed Zutter MM, Santoro SA, Staatz WD (1995) Re-expression of the alpha2beta1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc Natl Acad Sci USA 92:7411–7415PubMed
97.
Zurück zum Zitat Bogenrieder T, Herlyn M (2003) Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 22:6524–6536PubMed Bogenrieder T, Herlyn M (2003) Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 22:6524–6536PubMed
98.
Zurück zum Zitat Woodhouse EC, Chuaqui RF, Liotta LA (1997) General mechanisms of metastasis. Cancer 80:1529–1537PubMed Woodhouse EC, Chuaqui RF, Liotta LA (1997) General mechanisms of metastasis. Cancer 80:1529–1537PubMed
99.
Zurück zum Zitat Hood JD, Cheresh DA (2002) Role of integrins in cell invasion and migration. Nat Rev Cancer 2:91–100PubMed Hood JD, Cheresh DA (2002) Role of integrins in cell invasion and migration. Nat Rev Cancer 2:91–100PubMed
100.
Zurück zum Zitat Byers SW, Sommers CL, Hoxter B, Mercurio AM, Tozeren A (1995) Role of E-cadherin in the response of tumor cell aggregates to lymphatic, venous and arterial flow: measurement of cell–cell adhesion strength. J Cell Sci 108:2053–2064PubMed Byers SW, Sommers CL, Hoxter B, Mercurio AM, Tozeren A (1995) Role of E-cadherin in the response of tumor cell aggregates to lymphatic, venous and arterial flow: measurement of cell–cell adhesion strength. J Cell Sci 108:2053–2064PubMed
101.
Zurück zum Zitat Wolf K, Mazo I, Leung H (2003) Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 160:267–277PubMed Wolf K, Mazo I, Leung H (2003) Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 160:267–277PubMed
102.
Zurück zum Zitat Friedl P, Wolf K (2003) Tumour–cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3:362–374PubMed Friedl P, Wolf K (2003) Tumour–cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3:362–374PubMed
103.
Zurück zum Zitat Sahai E, Marschall CJ (2003) Differing modes of tumor cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol 5:711–719PubMed Sahai E, Marschall CJ (2003) Differing modes of tumor cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol 5:711–719PubMed
104.
Zurück zum Zitat Fukumura D, Yuan F, Monsky WL (1997) Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. Am J Pathol 151:679–688PubMed Fukumura D, Yuan F, Monsky WL (1997) Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. Am J Pathol 151:679–688PubMed
105.
Zurück zum Zitat Kikkawa H, Kaihou M, Horaguchi N (2002) Role of integrin alphavbeta3 in the early phase of liver metastasis: PET and IVM analyses. Clin Exp Metastasis 19:717–725PubMed Kikkawa H, Kaihou M, Horaguchi N (2002) Role of integrin alphavbeta3 in the early phase of liver metastasis: PET and IVM analyses. Clin Exp Metastasis 19:717–725PubMed
106.
Zurück zum Zitat Nip J, Shibata H, Loskutoff DJ et al (1992) Human melanoma cells derived from lymphatic metastasis use the integrin alpha(V)beta(3) to adhere to lymph node vitronectin. J Clin Invest 90:1406–1413PubMed Nip J, Shibata H, Loskutoff DJ et al (1992) Human melanoma cells derived from lymphatic metastasis use the integrin alpha(V)beta(3) to adhere to lymph node vitronectin. J Clin Invest 90:1406–1413PubMed
107.
Zurück zum Zitat Byzova TV, Kim W, Midura RJ et al (2000) Activation of integrin alpha(V)beta(3) regulates cell adhesion and migration to bone sialoprotein. Exp Cell Res 254:299–308PubMed Byzova TV, Kim W, Midura RJ et al (2000) Activation of integrin alpha(V)beta(3) regulates cell adhesion and migration to bone sialoprotein. Exp Cell Res 254:299–308PubMed
108.
Zurück zum Zitat Liapsi H, Flath H, Kitazawa S (1996) Integrin alpha V beta 3 expression by bone-residing breast cancer metastasis. Diagn Mol Pathol 5:127–135 Liapsi H, Flath H, Kitazawa S (1996) Integrin alpha V beta 3 expression by bone-residing breast cancer metastasis. Diagn Mol Pathol 5:127–135
109.
Zurück zum Zitat Sloan EK, Pouliot N, Stanley KL et al (2006) Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone. Breast Cancer Res 8:R20PubMed Sloan EK, Pouliot N, Stanley KL et al (2006) Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone. Breast Cancer Res 8:R20PubMed
110.
Zurück zum Zitat Bosman FT, Stamenkovic I (2003) Functional structure and composition of the extracellular matrix. J Pathol 200:423–428PubMed Bosman FT, Stamenkovic I (2003) Functional structure and composition of the extracellular matrix. J Pathol 200:423–428PubMed
111.
Zurück zum Zitat Hayashi C, Rittling S, Hayata T et al (2007) Serum osteopontin, an enhancer of tumor metastasis to bone, promotes B16 melanoma cell migration. J Cell Biochem 27 [Epub ahead of print] Hayashi C, Rittling S, Hayata T et al (2007) Serum osteopontin, an enhancer of tumor metastasis to bone, promotes B16 melanoma cell migration. J Cell Biochem 27 [Epub ahead of print]
112.
Zurück zum Zitat Desai B, Rogers MJ, Chellaiah MA (2007) Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells. Mol Cancer 6:18PubMed Desai B, Rogers MJ, Chellaiah MA (2007) Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells. Mol Cancer 6:18PubMed
113.
Zurück zum Zitat Paris S, Sesboue R, Chauzy C et al (2006) Hyaluronectin modulation of lung metastasis in nude mice. Eur J Cancer 42:3253–3259PubMed Paris S, Sesboue R, Chauzy C et al (2006) Hyaluronectin modulation of lung metastasis in nude mice. Eur J Cancer 42:3253–3259PubMed
114.
Zurück zum Zitat Bauerle T, Peterschmitt J, Hilbig H et al (2006) Treatment of bone metastasis induced by MDA-MB-231 breast cancer cells with an antibody against bone sialoprotein. Int J Oncol 28:573–583PubMed Bauerle T, Peterschmitt J, Hilbig H et al (2006) Treatment of bone metastasis induced by MDA-MB-231 breast cancer cells with an antibody against bone sialoprotein. Int J Oncol 28:573–583PubMed
115.
Zurück zum Zitat Jacob K, Webber M, Benayahu D et al (1999) Osteonectin promotes prostate cancer cell migration and invasion: a positive mechanism for metastasis to bone. Cancer Res 59:4453–4457PubMed Jacob K, Webber M, Benayahu D et al (1999) Osteonectin promotes prostate cancer cell migration and invasion: a positive mechanism for metastasis to bone. Cancer Res 59:4453–4457PubMed
116.
Zurück zum Zitat Wang H, Fu W, Im JH et al (2004) Tumor cell alpha3beta1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis. J Cell Biol 164:935–941PubMed Wang H, Fu W, Im JH et al (2004) Tumor cell alpha3beta1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis. J Cell Biol 164:935–941PubMed
117.
Zurück zum Zitat Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161–174PubMed Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161–174PubMed
118.
Zurück zum Zitat McCawley LJ, Matrisian LM (2001) Matrix metalloproteinases: they´re not just for matrix anymore. Curr Opin Cell Biol 13:534–540PubMed McCawley LJ, Matrisian LM (2001) Matrix metalloproteinases: they´re not just for matrix anymore. Curr Opin Cell Biol 13:534–540PubMed
119.
Zurück zum Zitat Mackay CR (2001) Chemokines: immunology’s high impact factors. Nat Immunol 2:95–101PubMed Mackay CR (2001) Chemokines: immunology’s high impact factors. Nat Immunol 2:95–101PubMed
120.
Zurück zum Zitat Schier AF (2003) Chemokine signaling: rules of attraction. Curr Biol 13:R192–R194PubMed Schier AF (2003) Chemokine signaling: rules of attraction. Curr Biol 13:R192–R194PubMed
121.
Zurück zum Zitat Youngs SJ, Ali SA, Taub DD et al (1997) Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer 71:257–266PubMed Youngs SJ, Ali SA, Taub DD et al (1997) Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer 71:257–266PubMed
122.
Zurück zum Zitat Zipin-Roitman A, Meshel T, Sagi-Assif O et al (2007) CXCL10 promotes invasion-related properties in human colorectal carcinoma cells. Cancer Res 67:3396–3405PubMed Zipin-Roitman A, Meshel T, Sagi-Assif O et al (2007) CXCL10 promotes invasion-related properties in human colorectal carcinoma cells. Cancer Res 67:3396–3405PubMed
123.
Zurück zum Zitat Burger JA, Burger M, Kipps TJ (1999) Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. Blood 94:3658–3667PubMed Burger JA, Burger M, Kipps TJ (1999) Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. Blood 94:3658–3667PubMed
124.
Zurück zum Zitat Burger M, Glodek A, Hartmann T et al (2003) Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells. Oncogene 22:8093–8101PubMed Burger M, Glodek A, Hartmann T et al (2003) Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells. Oncogene 22:8093–8101PubMed
125.
Zurück zum Zitat Zeelenberg IS, Ruuls-Van Stalle L, Roos E (2003) The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res 63:3833–3839PubMed Zeelenberg IS, Ruuls-Van Stalle L, Roos E (2003) The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res 63:3833–3839PubMed
126.
Zurück zum Zitat Cardones AR, Murakami T, Hwang ST (2003) CXCR4 enhances adhesion of B16 tumor cells to endothelial cells In vitro and in vivo via beta(1) integrin. Cancer Res 63:6751–6757PubMed Cardones AR, Murakami T, Hwang ST (2003) CXCR4 enhances adhesion of B16 tumor cells to endothelial cells In vitro and in vivo via beta(1) integrin. Cancer Res 63:6751–6757PubMed
127.
Zurück zum Zitat Dellacasagrande J, Schreurs OJ, Hofgaard PO et al (2003) Liver metastasis of cancer facilitated by chemokine receptor CCR6. Scand J Immunol 57:534–544PubMed Dellacasagrande J, Schreurs OJ, Hofgaard PO et al (2003) Liver metastasis of cancer facilitated by chemokine receptor CCR6. Scand J Immunol 57:534–544PubMed
128.
Zurück zum Zitat Kucia M, Jankowski K, Reca R et al (2004) CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 35:233–245PubMed Kucia M, Jankowski K, Reca R et al (2004) CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 35:233–245PubMed
129.
Zurück zum Zitat Fernandis AZ, Prasad A, Band H et al (2004) Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene 23:157–167PubMed Fernandis AZ, Prasad A, Band H et al (2004) Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene 23:157–167PubMed
130.
Zurück zum Zitat Wang J, Loberg R, Taichman RS (2006) The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis. Cancer Metastasis Rev 25:573–587PubMed Wang J, Loberg R, Taichman RS (2006) The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis. Cancer Metastasis Rev 25:573–587PubMed
131.
Zurück zum Zitat Wiley HE, Gonzalez EB, Maki W et al (2001) Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst 93:1638–1643PubMedCrossRef Wiley HE, Gonzalez EB, Maki W et al (2001) Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst 93:1638–1643PubMedCrossRef
132.
Zurück zum Zitat Pelletier AJ, van der Laan LJ, Hildbrand P et al (2000) Presentation of chemokine SDF-1 alpha by fibronectin mediates directed migration of T cells. Blood 96:2682–2690PubMed Pelletier AJ, van der Laan LJ, Hildbrand P et al (2000) Presentation of chemokine SDF-1 alpha by fibronectin mediates directed migration of T cells. Blood 96:2682–2690PubMed
133.
Zurück zum Zitat McNeel DG, Eickhoff J, Lee FT et al (2005) Phase I trial of a monoclonal antibody specific for alphavbeta3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion. Clin Cancer Res 11:7851–7860PubMed McNeel DG, Eickhoff J, Lee FT et al (2005) Phase I trial of a monoclonal antibody specific for alphavbeta3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion. Clin Cancer Res 11:7851–7860PubMed
134.
Zurück zum Zitat Ishida T, Ueda R (2006) CCR4 as a novel molecular target for immunotherapy of cancer. Cancer Sci 97:1139–1146PubMed Ishida T, Ueda R (2006) CCR4 as a novel molecular target for immunotherapy of cancer. Cancer Sci 97:1139–1146PubMed
Metadaten
Titel
The tumor cell–host organ interface in the early onset of metastatic organ colonisation
verfasst von
Peter Gassmann
Joerg Haier
Publikationsdatum
01.04.2008
Verlag
Springer Netherlands
Erschienen in
Clinical & Experimental Metastasis / Ausgabe 2/2008
Print ISSN: 0262-0898
Elektronische ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-007-9130-6

Weitere Artikel der Ausgabe 2/2008

Clinical & Experimental Metastasis 2/2008 Zur Ausgabe

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.